5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10112626 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature